ABN AMRO INVESTMENT SOLUTIONS
Position in LH — Labcorp Holdings Inc.
CIK 2080520
PARIS CEDEX 008, I0
Position in LH
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,339,800
+$551,644 QoQ
Shares Held
4,785
+62.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#415
of 1,044 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ABN AMRO INVESTMENT SOLUTIONS holds $159,360,178 across 12 Diagnostics & Research names. LH ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
126,330 | $63,336,808 | |
| 2 | DHR |
Danaher Corp /De/
|
297,041 | $56,580,369 | |
| 3 | DGX |
Quest Diagnostics Inc
|
98,878 | $20,957,191 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
20,692 | $3,998,108 | |
| 5 | NTRA |
Natera, Inc.
|
10,287 | $2,792,406 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
4,867 | $2,562,183 | |
| 7 | A |
Agilent Technologies, Inc.
|
17,091 | $2,270,197 | |
| 8 | WAT |
Waters Corp /De/
|
5,406 | $2,027,466 |
All Filings in LH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,339,800 | 4,785 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $788,156 | 2,954 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $627,450 | 2,501 | Shares | Defined | 2026-02-06 | |
| No filing history on record for this holder in this stock. | ||||||